foxo4-dri senolytic 2023 2024 study

foxo4-dri senolytic 2023 2024 study Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI: Human Trial Status, Cancer

Name: foxo4-dri senolytic 2023 2024 study Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI: Human Trial Status, Cancer
Brand: cantondelareina.com.ar
SKU: 74462355843
Price: 28.39 USD
Availability: InStock
Rating: 4.593100000000001 (7 reviews)

FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Senescence Inducers and Senolytics Pathways and Drugs Targeting Cellular Senescence[v1] FOXO4 DRI Wikipedia FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness

SKU: 74462355843 · From cantondelareina.com.ar

4.6

USD28.39 USD75.39

Pay in 4 interest-free payments of $7.10 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 14 - Sep 19

Description

DSIP (Delta Sleep - Inducing Peptide) is a naturally occurring nonapeptide studied for its regulatory role in neuroendocrine signaling, particularly in relation to circadian rhythm and stress-modulating pathways